Zacks Research Lifts Earnings Estimates for RenaissanceRe

RenaissanceRe Holdings Ltd. (NYSE:RNR) – Equities researchers at Zacks Research upped their FY2026 EPS estimates for shares of RenaissanceRe in a research note issued on Tuesday, February 17th. Zacks Research analyst Team now forecasts that the insurance provider will post earnings of $36.34 per share for the year, up from their previous forecast of $36.29. Zacks Research has a “Hold” rating on the stock. The consensus estimate for RenaissanceRe’s current full-year earnings is $26.04 per share. Zacks Research also issued estimates for RenaissanceRe’s Q4 2026 earnings at $9.78 EPS, Q3 2027 earnings at $5.62 EPS and FY2028 earnings at $42.80 EPS.

A number of other research firms have also commented on RNR. Wells Fargo & Company lifted their price objective on shares of RenaissanceRe from $281.00 to $306.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. The Goldman Sachs Group restated a “sell” rating and issued a $267.00 price target on shares of RenaissanceRe in a research report on Wednesday, January 7th. Keefe, Bruyette & Woods increased their price objective on RenaissanceRe from $314.00 to $323.00 and gave the stock a “market perform” rating in a research report on Monday, February 9th. Citigroup lifted their target price on RenaissanceRe from $328.00 to $333.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, UBS Group restated a “neutral” rating and set a $312.00 price target on shares of RenaissanceRe in a research note on Monday, February 9th. Four analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $309.60.

RenaissanceRe Stock Down 1.4%

RNR stock opened at $299.79 on Friday. The company has a market cap of $13.04 billion, a price-to-earnings ratio of 5.29, a price-to-earnings-growth ratio of 0.74 and a beta of 0.24. The company has a fifty day moving average price of $282.54 and a 200 day moving average price of $262.75. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.43 and a quick ratio of 1.43. RenaissanceRe has a 12 month low of $219.00 and a 12 month high of $315.88.

RenaissanceRe (NYSE:RNR) last issued its quarterly earnings data on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share for the quarter, beating analysts’ consensus estimates of $10.59 by $2.75. The company had revenue of $2.97 billion during the quarter, compared to analysts’ expectations of $1.73 billion. RenaissanceRe had a return on equity of 18.29% and a net margin of 20.88%.The firm’s revenue for the quarter was up 29.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $8.06 earnings per share.

Hedge Funds Weigh In On RenaissanceRe

Hedge funds have recently added to or reduced their stakes in the business. Hantz Financial Services Inc. grew its stake in RenaissanceRe by 707.1% in the 2nd quarter. Hantz Financial Services Inc. now owns 113 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 99 shares during the period. IFP Advisors Inc boosted its holdings in shares of RenaissanceRe by 160.0% during the second quarter. IFP Advisors Inc now owns 117 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 72 shares during the last quarter. Financial Consulate Inc. acquired a new stake in shares of RenaissanceRe during the third quarter worth $29,000. Huntington National Bank grew its position in shares of RenaissanceRe by 80.9% in the second quarter. Huntington National Bank now owns 123 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 55 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in RenaissanceRe by 151.9% in the third quarter. Farther Finance Advisors LLC now owns 131 shares of the insurance provider’s stock valued at $33,000 after purchasing an additional 79 shares during the last quarter. 99.97% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at RenaissanceRe

In related news, EVP Robert Qutub sold 5,000 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $305.75, for a total transaction of $1,528,750.00. Following the sale, the executive vice president owned 73,023 shares of the company’s stock, valued at approximately $22,326,782.25. The trade was a 6.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.30% of the company’s stock.

RenaissanceRe Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be given a $0.41 dividend. The ex-dividend date is Friday, March 13th. This is a positive change from RenaissanceRe’s previous quarterly dividend of $0.40. This represents a $1.64 annualized dividend and a yield of 0.5%. RenaissanceRe’s dividend payout ratio (DPR) is currently 2.82%.

RenaissanceRe News Roundup

Here are the key news stories impacting RenaissanceRe this week:

• Positive Sentiment: Zacks raised multi‑period and full‑year estimates — FY2027 was increased to $41.00 (from $40.25) and FY2028 was set at $42.80, signaling stronger medium‑term earnings power that can support a higher valuation.
• Positive Sentiment: Zacks bumped FY2026 slightly to $36.34 and raised several later quarter estimates (Q4 2026 to $9.78, Q4 2027 to $11.26, Q3 2027 to $5.62), suggesting improved reserve or underwriting expectations in those periods.
• Positive Sentiment: Several small quarter‑by‑quarter upgrades (e.g., Q3 2026 to $4.62) indicate Zacks sees pockets of stronger performance vs. prior forecasts — supportive for investor sentiment on future earnings momentum.
• Neutral Sentiment: Zacks retained a “Hold” rating on RNR despite the revisions and continues to show the consensus current full‑year estimate at $26.04 EPS — the rating tempering the upside from the estimate increases.
• Negative Sentiment: Zacks trimmed several near‑term quarterly forecasts: Q1 2026 cut to $10.86 (from $11.44), Q2 2026 to $11.07 (from $11.71), indicating weaker expected short‑term results that could pressure near‑term sentiment.
• Negative Sentiment: Early‑2027 quarters saw downgrades as well (Q1 2027 to $11.90 from $12.31; Q2 2027 to $12.22 from $12.46), highlighting mixed expectations and raising short‑term execution risk.
• Neutral Sentiment: Net impact: the mix of higher multi‑year EPS outlook and trimmed near‑term quarterlies means investors are weighing stronger long‑term profitability against potential short‑term execution variability.

About RenaissanceRe

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.